<DOC>
	<DOCNO>NCT00985816</DOCNO>
	<brief_summary>The investigator propose Phase II interventional trial investigate role Lactobacillus reuteri DSM 17938 intestinal motility immune response premature infant evaluate safety use probiotic population premature infant .</brief_summary>
	<brief_title>The Effects Lactobacillus Reuteri DSM 17938 Immunomodulation Gastric Motility Preterm Newborns</brief_title>
	<detailed_description>Hypothesis Administration Lactobacillus reuteri premature infant improve intestinal motility compare infant receive placebo . Primary Objective Evaluate effect L. reuteri intestinal motility measure gastric empty rate infant 21 consecutive day administration L. reuteri . Secondary Objectives 1 . Mechanisms action L. reuteri - L.reuteri impact host immune response determine fecal cytokine , sIgA calprotectin 21 day administration - L.reuteri rate colonization administration . 2 . Efficacy safety L. reuteri premature infant - Clinical beneficial effect secondary administration L. reuteri premature infant . The following clinical outcome identify compare group : - Number gastrointestinal symptom ( regurgitation , vomit , stasis ) - Days full feed . Number day reach full feed define &gt; 120cc/kg/day ) x2 day . - Days parenteral nutrition - Weight gain define number day need reach 150 % birth weight - Length hospital stay - Any possible side effect adverse event secondary administration L. reuteri premature infant . - Incidence late onset sepsis . - Incidence severity necrotizing enterocolitis categorize Bell 's classification - Use antibiotic ( number day antibiotics hospital stay ) - Mortality ( 28 day birth hospital discharge ) .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<criteria>Gestational age 30 32 week . Gestational age define best estimate base prenatal ultrasound first trimester , DLM and/or Balard Score birth . Cardiovascular ( respiratory ) instability 48 hour age Chromosomal anomaly . Major congenital anomaly ( complex cardiac anomaly , congenital hydrocephalus , renal dysplasia ) Congenital ( e.g . jejunal atresia ) acquire ( e.g . GI perforation ) gastrointestinal pathology preclude oral feed and/or require major surgical medical intervention Parental refusal Prior enrollment conflict clinical trial . Conflicting clinical trial intervention could modify outcome present study , example study could alter intestinal motility immune response premature infant .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Preterm</keyword>
	<keyword>newborn</keyword>
	<keyword>Gastric</keyword>
	<keyword>Motility</keyword>
	<keyword>Mucosal</keyword>
	<keyword>immunity</keyword>
</DOC>